s6y
Company name or ticker
Search
Jasper Therapeutics, Inc.
D
Exempt (Private) Offering
Filed
Wednesday, August 5, 2026
Accession number
0001213900-26-085315
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header